Dr. Kyle Smith, D.O

NPI: 1184663726
Total Payments
$3,233
2024 Payments
$831.99
Companies
12
Transactions
110
Medicare Patients
1,438
Medicare Billing
$109,446

Payment Breakdown by Category

Food & Beverage$3,065 (94.8%)
Education$167.98 (5.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,065 108 94.8%
Education $167.98 2 5.2%

Top Paying Companies

Company Total Records Latest Year
Teva Pharmaceuticals USA, Inc. $1,094 23 $0 (2024)
Otsuka America Pharmaceutical, Inc. $920.81 31 $0 (2024)
Neurocrine Biosciences, Inc. $695.37 31 $0 (2024)
Sunovion Pharmaceuticals Inc. $116.84 1 $0 (2019)
Vanda Pharmaceuticals Inc. $109.43 6 $0 (2022)
Lundbeck LLC $107.72 6 $0 (2024)
Axsome Therapeutics, Inc. $44.16 1 $0 (2023)
Janssen Pharmaceuticals, Inc $37.27 2 $0 (2023)
PFIZER INC. $32.35 2 $0 (2017)
Avanir Pharmaceuticals, Inc. $25.79 2 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $831.99 25 Teva Pharmaceuticals USA, Inc. ($605.18)
2023 $933.86 25 Teva Pharmaceuticals USA, Inc. ($421.88)
2022 $644.54 16 Otsuka America Pharmaceutical, Inc. ($345.95)
2021 $128.97 7 Neurocrine Biosciences, Inc. ($87.56)
2020 $221.19 13 Neurocrine Biosciences, Inc. ($115.17)
2019 $353.80 15 Neurocrine Biosciences, Inc. ($133.51)
2018 $75.40 6 Neuronetics, Inc. ($23.57)
2017 $43.03 3 PFIZER INC. ($32.35)

All Payment Transactions

110 individual payment records from CMS Open Payments — Page 3 of 5

Date Company Product Nature Form Amount Type
11/30/2022 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $20.60 General
Category: PSYCHIATRY
11/03/2022 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $27.23 General
Category: Central Nervous System
10/27/2022 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $18.00 General
Category: PSYCHIATRY
10/26/2022 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $34.02 General
Category: Neuropsychiatry
10/05/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $119.74 General
Category: PSYCHIATRY
10/03/2022 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $20.25 General
Category: PSYCHIATRY
09/28/2022 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage Cash or cash equivalent $133.18 General
Category: Neuropsychiatry
08/30/2022 Vanda Pharmaceuticals Inc. HETLIOZ (Drug), FANAPT Food and Beverage In-kind items and services $31.04 General
Category: NON-24-HOUR SLEEP-WAKE DISORDER
08/25/2022 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $16.04 General
Category: PSYCHIATRY
08/17/2022 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $13.11 General
Category: PSYCHIATRY
07/21/2022 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $16.93 General
Category: Central Nervous System
07/14/2022 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $21.13 General
Category: PSYCHIATRY
06/28/2022 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $13.05 General
Category: PSYCHIATRY
06/23/2022 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $22.48 General
Category: Central Nervous System
06/02/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $121.32 General
Category: PSYCHIATRY
03/31/2022 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $16.42 General
Category: PSYCHIATRY
12/07/2021 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $13.77 General
Category: PSYCHIATRY
10/06/2021 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $18.58 General
Category: NEUROLOGY
06/21/2021 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $15.44 General
Category: PSYCHIATRY
05/25/2021 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $18.74 General
Category: NEUROLOGY
05/04/2021 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $12.20 General
Category: PSYCHIATRY
04/21/2021 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $26.48 General
Category: NEUROLOGY
02/24/2021 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $23.76 General
Category: NEUROLOGY
12/09/2020 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $22.31 General
Category: NEUROLOGY
12/01/2020 Vanda Pharmaceuticals Inc. HETLIOZ (Drug), FANAPT Food and Beverage In-kind items and services $15.85 General
Category: NON-24-HOUR SLEEP-WAKE DISORDER

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 201 420 $73,653 $19,554
2022 2 274 759 $53,093 $22,441
2021 2 459 1,127 $90,051 $36,058
2020 3 504 1,083 $84,561 $31,395
Total Patients
1,438
Total Services
3,389
Medicare Billing
$109,446
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90792 Psychiatric diagnostic evaluation with medical services Office 2023 70 70 $23,520 $9,036 38.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 109 328 $41,984 $8,134 19.4%
90791 Psychiatric diagnostic evaluation Office 2023 22 22 $8,149 $2,383 29.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 199 619 $43,275 $18,947 43.8%
99441 Telephone medical discussion with physician, 5-10 minutes Office 2022 75 140 $9,818 $3,493 35.6%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 311 813 $65,312 $26,283 40.2%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Office 2021 148 314 $24,739 $9,775 39.5%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 351 848 $62,950 $22,938 36.4%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Office 2020 141 223 $19,428 $7,405 38.1%
90792 Psychiatric diagnostic evaluation with medical services Office 2020 12 12 $2,183 $1,051 48.2%

About Dr. Kyle Smith, D.O

Dr. Kyle Smith, D.O is a Psychiatry healthcare provider based in Troy, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184663726.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Smith, D.O has received a total of $3,233 in payments from pharmaceutical and medical device companies, with $831.99 received in 2024. These payments were reported across 110 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($3,065).

As a Medicare-enrolled provider, Smith has provided services to 1,438 Medicare beneficiaries, totaling 3,389 services with total Medicare billing of $109,446. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Troy, MI
  • Active Since 06/06/2006
  • Last Updated 06/02/2014
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1184663726

Products in Payments

  • INGREZZA (Drug) $669.28
  • REXULTI (Drug) $634.62
  • Austedo XR (Drug) $589.18
  • NUEDEXTA (Drug) $260.09
  • UZEDY (Drug) $227.86
  • ABILIFY MAINTENA (Drug) $159.61
  • LATUDA (Drug) $116.84
  • AUSTEDO (Drug) $108.68
  • HETLIOZ (Drug) $59.87
  • Fanapt (Drug) $49.56
  • Auvelity (Drug) $44.16
  • INVEGA SUSTENNA (Drug) $37.27
  • QUILLIVANT XR (Drug) $32.35
  • NEUROSTAR TMS THERAPY (Device) $23.57
  • VYVANSE (Drug) $15.09
  • MYDAYIS (Drug) $10.68

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Troy